If a supplied lot fails agreed specifications, we’ll replace it at no cost or refund its purchase price in full.
Quality test failed? Free replacement or full refund.
Off-spec? Free replacement or full refund.
PCAC will review 7 peptides for the 503A bulks list, BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax, Epithalon. Read our briefing →
PCAC will review 7 peptides for the 503A bulks list. Read →
FDA PCAC reviews 7 peptides in July. Read →
For Med-Spas & Aesthetic Brands
Med-spa peptide procurement runs differently from compounding pharmacy or research-lab buying. The workhorse SKUs are different (GHK-Cu, SNAP-8, Matrixyl, B-12, lipotropics), the documentation expectations are different (INCI naming, cosmetic-grade specs), and the OEM pathway, private-label finished products under the spa's brand, is a major commercial route. PeptideXpo's catalog and OEM service cover both bulk-active procurement and finished-product development.
Why med-spa brands choose PeptideXpo
For cosmetic projects, ask sales to confirm the supplied form, applicable batch COA, SDS, and available INCI support. Destination-market and formulation documents are project-specific and are included only when confirmed in the written quotation.
Private-label OEM finished-product service runs end-to-end: bulk peptide procurement, finished-formulation development (or porting an existing formula), stability testing in your specific carrier system, primary packaging sourcing, secondary packaging (cartons, IFU, regulatory disclaimers), and finished-goods QC. First-run timeline is 8-14 weeks from signed brief; recurring orders compress to 4-8 weeks against forecast.
For in-clinic injectable workflows (IM B-12, MIC trio, IV NAD+, IV Glutathione), we supply bulk lyophilized or pre-mixed aqueous solution per the format your clinical preparation requires. Lipotropic-injection composition (the MIC + B-vitamin combinations) is fully customizable through the OEM service for clinics building their own branded blends.
Regulatory advisory specific to the destination market, particularly important for the contested zones (Korean-origin lipolytic injectables, IV glutathione for dermal pigmentation, Melanotan-class melanocortin agonists). We won't dispense legal advice, but we describe the destination market's current treatment of similar products so your in-house compliance team has the context to make the call.
Private-label vials with your branding
Cosmetic-grade documentation
Region-aware compliance review
Direct WhatsApp support
Regions served: USA · MENA · LATAM · APAC
Curated catalog
The peptides and supporting products most commonly procured by med-aesthetic clinics and OEM brands in our buyer base.
BPC-157 + TB-500 repair-stack blend
3-mer
Copper tripeptide-1
Acetyl octapeptide-3 · cosmetic peptide
18-mer
Palmitoyl pentapeptide-4
3-mer
Copper peptide AHK
GH-axis blend (CJC-1295 no DAC + Ipamorelin)
Nicotinamide adenine dinucleotide
Fatty-acid-transport nutrient
Frequently asked
Yes. Cosmetic-grade peptides ship with the INCI name on the SDS, Copper Tripeptide-1 (GHK-Cu), Acetyl Octapeptide-3 (SNAP-8), Palmitoyl Pentapeptide-4 (Matrixyl), and equivalents for the rest of the cosmetic catalog. The INCI documentation supports finished-product notification in EU CPNP, FDA cosmetic monograph workflows, and equivalent registries. The cosmetic-grade specification sheet is separate from the research-grade COA and includes the documentation depth your finished-product regulatory pathway requires.
End-to-end: formulation development (or porting an existing formula to our manufacturing line), stability testing in the specific carrier system (typical accelerated 40°C/75% RH + real-time 25°C/60% RH protocols), primary packaging sourcing (airless-pump bottles, jars, ampoules, multi-dose vials), secondary packaging (brand cartons, IFU/insert design, regulatory disclaimers per destination market), and finished-goods QC release. Typical first-run MOQ is 3,000 units per SKU; lower MOQ available for pilot launches with adjusted pricing. Full timeline 8-14 weeks from signed brief to first shipment.
Both. Bulk lyophilized B-12, L-Carnitine, and MIC-trio components ship in standard mg fills. Pre-mixed aqueous formulations (1 mg/mL B-12 solution, 600 mg / 1200 mg L-Carnitine solution, Lipo-C aqueous blends at 10 mL) are also available, these are commonly used by med-spa clinics that prefer ready-to-use IM injection format. Custom blends with specific MIC ratios or alternative B-vitamin forms (methylcobalamin instead of cyanocobalamin) are available through the OEM service.
Lemon Bottle and similar Korean-origin aesthetic injectables have varied regulatory acceptance: approved or tolerated in several Asian markets where they originate; off-label or grey-market in the UK and parts of EU; prohibited or strongly restricted in the US. The composition uses ingredients that are individually established but the finished-product approval status is jurisdiction-specific. We distribute only to qualified buyers who have verified the product's regulatory status in their destination market and have the appropriate aesthetic-injectable licensing. Specify the destination at quote stage so our regulatory team can confirm the procurement fit.
The realistic launch timeline depends on how much formulation work the brand brings versus needs developed from scratch. Brand brings an existing formula plus packaging design: 8-10 weeks from signed brief to first shipment. Brand brings a concept plus reference products but needs formulation work: 12-16 weeks. Brand starts from scratch with no prior formulation: 16-24 weeks because the stability-testing protocol becomes the critical-path constraint. Recurring orders after first launch compress to 4-8 weeks against forecast. Discuss the launch timeline at quote stage so we can calibrate the development workflow accordingly.
Related reading
A first reply within 24 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams read every inquiry before any price goes out.
